| J2350 | Injection, ocrelizumab, 1 mg | 9,300 | $40 | $353.4K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 18,270 | $10 | $91.3K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 170 | $90 | $14.6K |
| 64615 | The provider bilaterally administers a chemical compound to the muscles innervated by the trigeminal, facial, cervical spinal, and accessory nerves. The goal of this procedure is to paralyze the… | 90 | $100 | $9K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 60 | $120 | $7.3K |
| 95885 | The provider assesses the electrical activity of a muscle in the extremity and related paraspinal areas. At the same session as a separately reportable nerve conduction studies. The provider performs… | 130 | $40 | $5.5K |
| 95913 | In this procedure, the provider performs 13 or more nerve conduction studies, a diagnostic test to evaluate function, especially the electrical conduction ability of the motor and sensory nerves of… | 20 | $210 | $5.1K |
| 95910 | In this procedure, the provider performs seven or eight nerve conduction studies, a diagnostic test to evaluate the function, especially the electrical conduction ability of the motor and sensory… | 30 | $120 | $4K |
| 95912 | In this procedure, the provider performs eleven or twelve nerve conduction studies, a diagnostic test to evaluate function, especially the electrical conduction ability of the motor and sensory… | 20 | $160 | $3K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 20 | $120 | $3K |